Merrimack postpones IPO

Merrimack Pharmaceuticals Inc. (Cambridge, Mass) has postponed its IPO, according to a banker familiar with the deal who did not want to be named. The company had planned to sell 16.7 million shares at $8-$10. A $9 price would have raised $150 million and valued the company at $852.8 million. ...